From August 21, 2023 to November 24, 2023, the company has repurchased 618,077 shares, representing 0.15% for CNY 20.01 million. With this, the company has completed the repurchase of 618,077 shares, representing 0.15% for CNY 20.01 million under the buyback announced on August 22, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.26 CNY | -2.83% | -1.07% | -36.73% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.73% | 1.11B | |
+55.95% | 819B | |
-6.98% | 351B | |
+19.08% | 329B | |
+9.05% | 298B | |
+17.21% | 242B | |
+2.25% | 225B | |
+13.33% | 217B | |
+8.91% | 168B | |
-3.44% | 158B |
- Stock Market
- Equities
- 688105 Stock
- News Nanjing Vazyme Biotech Co.,Ltd
- Tranche Update on Nanjing Vazyme Biotech Co.,Ltd's Equity Buyback Plan announced on August 22, 2023.